Dr. Reddy's Laboratories Limited vs Mankind Pharma Limited

A side-by-side comparison of Dr. Reddy's Laboratories Limited (DRREDDY) and Mankind Pharma Limited (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Dr. Reddy's Laboratories Limited leads DRREDDY vs MANKIND on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability04
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

DRREDDY takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

24.46
P/E ratio
49.09
2.50
P/B ratio
5.69
0.70%
Dividend yield
0.04%
₹50.41
EPS
₹46.35

Profitability

MANKIND takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

11.07%
Return on equity
11.74%
12.64%
Return on capital
13.14%
19.15%
EBITDA margin
25.34%
12.34%
Net margin
13.57%

Growth

MANKIND takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.96%
Revenue CAGR (3Y)
17.73%
-2.66%
Profit CAGR (3Y)
13.96%

Size & financial health

DRREDDY takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.03L Cr
Market cap
₹93,968 Cr
₹33,700 Cr
Revenue
₹14,278 Cr
₹4,158 Cr
Net profit
₹1,938 Cr
0.20
Debt / equity
0.39
Dr. Reddy's Laboratories Limited
  • + ["Company has delivered good profit growth of 16.3% CAGR over last 5 years"]
  • − []
Mankind Pharma Limited
  • + ["Company has delivered good sales growth of 18.1% CAGR over last 5 years"]
  • − ["Stock is trading at 5.77 times its book value"]
Dr. Reddy's Laboratories Limited full analysis Mankind Pharma Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.